Zepbound Offers Unique Health Benefits : Obstructive Sleep Apnea (OSA): Tirzepatide (Zepbound) is the only medication in its class FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity
This ensures faster, more reliable results
Whether you're considering Noom, Hims, or another provider, genetic insight can complement clinical evaluation
By 2030, Circana predicts that GLP-1 users will account for 35% of all food and beverage sales
Our assay provides a more sensitive, specific, and flexible tool for use with human, mouse, and rat models in various states such as fasted and fed, glucose-stimulated insulin secretion, and diet-induced obesity, as well as perifusion.
Many antioxidants exhibit impressive antioxidant/radical scavenging activity in various in vitro tests